About 130 PE-backed DSOs operated in 2025 with more than 100 dental transactions per year since 2021 according to FOCUS Investment Banking. Add-on practices typically transact at 5x to 8x EBITDA, platforms at 9x to 11x. Buyers evaluate recurring hygiene production, payer mix, SOPs, KPI dashboards, centralized scheduling, revenue cycle management, compliance, cloud PMS, and automated patient communication. The operational standards that prepare a practice for sale also strengthen independent practice performance.

This guide is for practice owners considering a sale to a DSO, evaluating succession and exit timing, or competing with DSO-backed practices in a saturated market. It covers current valuation multiples and what drives them, current PE activity in dental, what buyers evaluate at acquisition, how DSO-backed practices operate differently from independents, what operational technology investments lift pre-sale EBITDA quality, the decision framework for sale versus independence, the operational pattern for competing with DSOs, and the regulatory environment shaping consolidation.

What multiples do DSOs pay for dental practices in 2026?

FOCUS Investment Banking publishes a framework of 5x to 8x EBITDA for add-on practices and 9x to 11x for platforms. The breakdown by EBITDA size band is more granular.

EBITDA range	Typical multiple range	Transaction type
Under $1 million	5x to 7x	Add-on
$1 million to $3 million	7x to 9x	Add-on or small platform
$3 million to $5 million	9x to 11x	Platform
$5 million-plus	11x and above in some transactions	Platform

Multiples depend on EBITDA quality, not just EBITDA size. A $1 million EBITDA practice with strong recurring hygiene, documented SOPs, clean payer mix, and operational dashboards typically transacts at the upper end of its band; a same-EBITDA practice with provider-dependent revenue, no documentation, and inconsistent operations transacts at the lower end. Buyers pay for predictability.

How active is private equity in dental practice acquisition right now?

Dental remains one of the most active healthcare verticals for private equity and DSO platform formation. Becker’s reported nearly 200 DSO transactions in 2024 with concentration in California, Florida, New York, Pennsylvania, Illinois, and New Jersey. The top 10 DSOs supported about 7,000 offices and the top five supported more than 10,000 dentists.

The trajectory has been consistent. PE affiliation among dentists nearly doubled from 6.6 percent in 2015 to 12.8 percent in 2021 according to Health Affairs research summarized in ADA News. Transactions rose from fewer than 20 per year between 2004 and 2015 to 96 in 2021. Practice ownership among all dentists fell from 84.7 percent in 2005 to 72.5 percent in 2023 with DSO affiliation reaching 16 percent by 2024.

Major active DSO platforms include Heartland Dental (KKR and Ontario Teachers’ Pension Plan), Aspen Dental and TAG (Ares Management and Leonard Green), Smile Brands (Gryphon Investors), Sonrava Health and Western Dental (New Mountain Capital), Pacific Dental Services, Dental Care Alliance, Great Expressions, and MB2 Dental.

What do DSO acquirers actually evaluate?

FOCUS Investment Banking lists the EBITDA-quality signals dental buyers evaluate at acquisition. The list is concrete and operational rather than abstract.

Signal	What buyers look for
Recurring hygiene production	Predictable revenue base from regular hygiene visits, ideally 25 to 33 percent of total production
Payer mix	Diversified payer base, not over-concentrated in low-margin contracts
Documented SOPs	Written procedures for case presentation, recall, financing, and clinical workflows
KPI dashboards	Active weekly review of operational metrics, not just monthly financials
Centralized scheduling	Consistent scheduling logic across providers and locations
Revenue cycle management	Collections discipline, accounts receivable aging, insurance follow-through
Compliance posture	OSHA, HIPAA, state board, and PPO contract compliance documentation
Cloud PMS	Modern scheduling and clinical software with reporting capability
Automated patient communication	Reminders, recall campaigns, two-way texting, online booking

Buyers pay for predictability in each of these areas. The diligence process is operational, not just financial. A practice with strong financial performance but weak operational documentation typically transacts at a lower multiple than one with the same financial performance and complete operational documentation, because the buyer takes on integration risk that the documentation would have absorbed.

How do DSO-backed practices operate differently from independents?

The operating differences are concrete and visible inside the practice. Most independents can identify their gaps quickly when the comparison is laid out plainly.

Operating area	DSO-backed pattern	Independent practice gap
PMS and data	Cloud PMS, centralized reporting, multi-location dashboards	Legacy PMS, local reporting, inconsistent KPI review
Patient communication	Automated reminders, online booking, two-way texting, recall campaigns, review requests	Manual callbacks, inconsistent recall outreach, weak review capture
Case presentation	Standardized scripts, treatment coordinator workflows, imaging and AI overlays, financing visibility	Dentist-dependent presentation style, inconsistent visual use
Revenue cycle	Centralized claims, payment posting, eligibility verification, collections	Front-desk-dependent collections and insurance follow-up
Patient education	Standardized chairside and lobby education content	Ad hoc pamphlets, unused monitors, inconsistent messaging
Marketing and reputation	Centralized local SEO, reviews, paid media, brand standards	Owner-managed marketing, weaker measurement
Compliance and procurement	Central policies, vendor contracts, training, audit trails	Lower purchasing leverage, less formal documentation

The independent-practice gap is not a clinical-quality gap. It is an operational consistency gap. The standardization that DSO-backed practices have built across these seven areas is what produces the EBITDA quality buyers pay multiples for.

What operational technology investments lift pre-sale EBITDA quality?

Five investment categories show up consistently in pre-sale operational reviews and translate to EBITDA quality buyers evaluate.

Cloud PMS migration moves the practice from local-server software to platforms with reporting capability, multi-location consolidation, and modern integration options. Dentrix Ascend, Open Dental, and Carestack are common destinations.

Automated patient communication replaces manual reminder calls and recall postcards with platforms like Weave, NexHealth, or Solutionreach.

KPI dashboards and analytics make weekly operational review possible at the practice and provider level. Dental Intelligence, Practice by Numbers, and PMS-native dashboards are the typical implementations.

Standardized case presentation infrastructure includes operatory monitors, lobby education content, and consistent treatment plan visualization workflows. This is the layer where most independents have hardware in place but inconsistent or absent content management.

Revenue cycle management discipline includes documented payer mix, accounts receivable aging policies, eligibility verification workflows, and collections cadence.

Patient-facing display infrastructure is one component of the standardized case presentation layer above. It is not by itself a valuation multiple driver. The defensible position is that display infrastructure is part of the operating-system maturity buyers evaluate, alongside cloud PMS, automated communication, and KPI discipline.

Should you sell to a DSO or stay independent?

The decision depends on factors that are specific to each practice owner: control preferences, valuation timing, market saturation in the local geography, family succession options, and personal exhaustion or energy. The decision is rarely purely financial.

Holland and Knight’s 2025 DSO trend report described middle-market and lower-middle-market DSO activity as robust while large DSO investments faced more complex deal structures, regulatory changes, and tighter lender expectations around compliance and integration. The market remains active, but at the small-to-mid end where most independent practices fall, the buyer pool is competitive.

The practical observation: the operational standards that prepare a practice for sale also strengthen independent practice performance. The cloud PMS, automated communication, standardized case presentation, KPI dashboards, and patient-facing education standardization that increase the multiple at sale also reduce avoidable revenue leakage day-to-day. The pre-sale work compounds into independent practice value either way, which lowers the regret cost of investing in operational maturity even before the sale decision is made.

How do you compete with DSO-backed practices if you stay independent?

Independent practices in PE-saturated markets compete through operational execution. The pattern is consistent and does not require copying corporate branding.

Standardize case presentation across providers and operatories. Implement consistent visual workflows, financing visibility at decision moments, and treatment coordinator handoffs. The largest source of unmanaged variance in case acceptance is provider-to-provider workflow difference, not communication style. See the case acceptance guide for tactical specifics.

Standardize recall and hygiene retention. Implement automated reminders alongside in-practice education that makes the next visit feel necessary before the patient exits. See the recall and hygiene retention guide for the workflow.

Run a weekly KPI review. Track new patients, case acceptance, hygiene reappointment, no-show percent, and unscheduled treatment dollars. Adjust workflow based on what the dashboard shows, not just review the numbers.

Generate reviews systematically. Local SEO ranking and conversion are review-volume sensitive. In-practice review prompts at moments of patient satisfaction outperform sporadic verbal asks.

Patient-facing display infrastructure is the standardization layer for the patient-facing operations across these tactics. See how CastHub fits an independent practice’s competitive operational stack.

What does the regulatory environment look like for DSO consolidation?

Federal scrutiny of healthcare consolidation increased through 2024 and 2025. The FTC, DOJ, and HHS launched a cross-government inquiry into corporate and private-equity control in healthcare in 2024. A 2025 HHS report summarized public concerns about consolidation, prices, access, and quality.

Dental-specific peer-reviewed evidence on PE outcomes is emerging. A Health Services Research study summarized in Dental Economics found that PE-acquired dental offices submitted charges 3.3 percent higher after acquisition and more than 5 percent higher by year three, while negotiated payments did not significantly change. The study also found increased nonpreventive and nondiagnostic procedures and increased implant procedures per visit, with implants up 14 percent at baseline and 46 percent by year four.

The consolidation story is contested. DSO advocates point to administrative support, technology access, capital, and reduced nonclinical burden for dentists. Critics point to PE pressure, overtreatment risk, and reduced clinical autonomy. The regulatory environment is increasing diligence requirements on transactions but is not currently constraining transaction volume in the small-to-mid market where most independent practice sales occur.

For the broader practice revenue framework, see the dental practice revenue guide. For specific levers, see the case acceptance guide and the recall and retention guide.